0AB6 fundamentals
HYLORIS PHARMACEUTICALS SA NPV financial statements, including revenue, expenses, profit, and loss
The total revenue of 0AB6 for the last semiannual is 4.15 M EUR, and it's 348.00% higher compared to the previous semiannual. The net income of H1 24 is -3.48 M EUR.
Q1 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q1 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM